The Week That Brought the Dow to Its Knees

Two medical stocks made big headlines this week

Managing Editor
Mar 13, 2020 at 3:17 PM
facebook twitter linkedin

Triggering yet another whirlwind week on Wall Street, coronavirus fears continue to rise, as a rapid increase in cases both worldwide and within the U.S. shake investors. Markets began the week with catastrophic losses, including that of oil, which experienced its worst single-session drop since 1991. The broad market rallied Tuesday, but by Wednesday suffered a selloff that sent indexes into bear-market territory following the World Health Organization's (WHO) declaration that COVID-19 was a "pandemic." Thursday marked the Dow Jones Industrial Average's (DJI) worst daily drop since 1987, though some of these losses were pared on Friday, as stocks moved into recovery mode.

Medical Stocks Making Moves

It won't come as a shock to know that drug stocks made headlines once again this week. Eli Lilly (LLY) was given high praise out of Goldman Sachs on Wednesday, added to the firm's "Conviction Buy" list despite coronavirus concerns. Meanwhile, the Food and Drug Administration (FDA) had Soliton (SOLY) stock soaring after the medical device company received 510(k) Premarket Notification clearance for its Generation II tattoo removal device.

2 Stocks Blasted by C-Suite Buzz

With rapid headwinds taking out travel stocks left and right, it was no surprise when Southwest Airlines' (LUV) CEO Garry Kelly announced Tuesday he would be taking a 10% pay cut to combat company losses. Meanwhile, tech retailer Best Buy (BBY) suffered a steep pullback after announcing Executive Chairman Hubert Joly's resignation. 

Also making headlines this past week was PepsiCo (PEP). Specifically, the Coca-Cola (KO) rival sank lower after revealing its plans to buyout Rockstar Energy for $3.85 billion.

All Eyes on Fed

Amid the current volatility climate on Wall Street, we took a closer look at how stocks tend to behave during a market bounce, as well as the SPY level to watch before March's options expiration. Looking ahead to next week, the Fed will hold its two-day meeting beginning on Tuesday, and culminate in remarks from Fed Chair Jerome Powell Wednesday afternoon. Also slated to debut will be, retail and jobs data, as well as a handful of notable earnings reports.


Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

Schaeffer's Daily Bulletin Offer


Special Offers from Schaeffer's Trading Partners